Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$3.66 - $6.77 $4.58 Million - $8.47 Million
-1,250,618 Reduced 50.02%
1,249,382 $4.91 Million
Q3 2022

Nov 14, 2022

SELL
$4.68 - $8.34 $1.86 Million - $3.31 Million
-397,300 Reduced 13.71%
2,500,000 $13.3 Million
Q2 2022

Aug 15, 2022

SELL
$4.87 - $9.41 $2.94 Million - $5.67 Million
-602,700 Reduced 17.22%
2,897,300 $19 Million
Q2 2021

Aug 13, 2021

BUY
$24.34 - $38.34 $5.59 Million - $8.8 Million
229,500 Added 7.02%
3,500,000 $94.2 Million
Q1 2021

May 17, 2021

BUY
$24.74 - $40.2 $24.8 Million - $40.3 Million
1,001,681 Added 44.15%
3,270,500 $93.1 Million
Q4 2020

Feb 16, 2021

BUY
$21.68 - $51.61 $3.21 Million - $7.65 Million
148,194 Added 6.99%
2,268,819 $64.3 Million
Q3 2020

Nov 16, 2020

BUY
$18.07 - $31.84 $32,634 - $57,503
1,806 Added 0.09%
2,120,625 $65.5 Million
Q2 2020

Aug 14, 2020

BUY
$20.1 - $24.69 $42.6 Million - $52.3 Million
2,118,819 New
2,118,819 $44.5 Million

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $166M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.